Top Emerging Trends

Recent Posts

Historic Moment: 3 Women to Serve Together on Supreme Court as Senate Confirms Elena Kagan
Posted on 5 Aug 2010 by Gregg Lawson

WASHINGTON, D.C. - The Senate voted 63-37 today to confirm Elena Kagan as the 112th justice and fourth woman to serve on the U.S. Supreme Court. Five Republicans, the two Senate independents and all but one Democrat supported President Barack Obama's... Read More

Chinese-Government-Controlled Drywall Manufacturer to Appeal $2,600,000 Default Judgment to Fifth Circuit
Posted on 15 Jun 2010 by Gerald C. Matics

NEW ORLEANS - (Mealey's) A key Chinese drywall manufacturer that had a default judgment for more than $2.6 million entered against it in May finally appeared in federal court June 10, only to serve notice that it is appealing the judgment and all... Read More

FDA Advisory Committee Votes to Recommend Keeping Anti-Diabetes Drug Avandia On The Market
Posted on 18 Jul 2010 by Tom Moylan

GAITHERSBURG, Md. - (Mealey's) A majority of Food and Drug Administration advisers voted July 14 to keep Avandia on the market but split on whether the anti-diabetes drug made by GlaxoSmithKline PLC (GSK) should carry additional warnings about its... Read More

Pfizer Petition for Certiorari Denied by U.S. Supreme Court In Trovan Nigerian Clinical Trial Case
Posted on 2 Jul 2010 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 29 rejected Pfizer Inc.'s petition for a writ of certiorari involving the claims of Nigerians allegedly injured during a 1996 Trovan clinical trial in their country, allowing the claims... Read More

Glaxo to take $2.36 Billion Charge to Reflect Settlement of Most Avandia and Paxil Product Liability Cases and Other Legal Issues
Posted on 17 Jul 2010 by Tom Moylan

LONDON - (Mealey's) GlaxoSmithKline PLC (GSK) on July 15 said it expects to take a $2.36 billion charge against earnings to settle several legal issues, including settling "the substantial majority" of Avandia product liability cases and... Read More